Dewpoint Therapeutics, Inc., a clinical-stage biotechnology company pioneering condensate-modulating therapeutics, today announced that the first patient has been dosed in a Phase 1a/2a clinical trial ...

Third Arc Bio Inc., a clinical stage biotech company developing novel multifunctional antibodies for a range of oncology and immunology & inflammation (I&I) indications, today announced the closing of ...

Failure of Universal mRNA Boosting Exposes Flaws in Public Health Policy** The misguided approach to universal mRNA boosting during the COVID-19 pandemic has exposed a critical failure in public ...

Swine viruses remain a major threat to animal health, food security, and global trade, with substantial economic impacts on ...

Neuroinflammation represents a hallmark of many degenerative diseases, such as Alzheimer’s Disease, Parkinson’s Disease, amyotrophic lateral sclerosis, multiple sclerosis, multiple system atrophy and ...

A new study published in the journal Medicine by researchers from Korea University College of Medicine provides further ...

EDN announces this year’s winners of the Electronic Products Product of the Year Awards, selected by the editors.

Attaching amino acids to a hydrophobic organic molecule allows them to self-assemble into rare, knotted structures with ...

Each Olympic cycle, athletes and support staff chase the latest cutting-edge knowledge in pursuit of Gold. In the Winter ...

Lam Research and CEA‑Leti have signed a new multi‑year research agreement aimed at advancing the fabrication of ...

Your surroundings may influence your social behavior more than you realize. New research from the Brain Research Institute at ...

In this Q&A, Avitzur breaks down the study’s findings and suggests how the information can be used to advance PF research and treatments. This transcript has been lightly edited for clarity. AJMC: ...